Prostate Specific Antigen Screening and Active Surveillance in the Elderly

References 

1. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149:185
2. DeAntoni EP, Crawford ED, Oesterling JE, Ross CA, Berger ER, McLeod DG, et al. Age- and race-specific reference ranges for prostate specific antigen from a large community-based study. Urology. 1996;48:234
   • Abstract
   • Full-Text PDF (752 KB)
   • CrossRef
3. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, et al. Serum prostate-specific antigen in a community-based population of healthy men (Establishment of age-specific reference ranges). JAMA. 1993;270:860
   • MEDLINE
4. Konety BR, Sharp VJ, Verma M, Williams RD Iowa Prostate Cancer Consensus Panel. Practice patterns in screening and management of prostate cancer in elderly men. Urology. 2006;68:1051
   • Abstract
   • Full Text
   • Full-Text PDF (106 KB)
   • CrossRef
5. Konety BR, Sharp VJ, Raut H, Williams RD. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus. Urology. 2008;71:511
   • Abstract
   • Full Text
   • Full-Text PDF (75 KB)
   • CrossRef
6. Dyche DJ, Ness J, West M, Allareddy V, Konety BR. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. J Urol. 2006;175:2078
   • Abstract
   • Full Text
   • Full-Text PDF (105 KB)
   • CrossRef
7. Fowler FJ, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526
   • Abstract
   • Full Text
   • Full-Text PDF (349 KB)
   • CrossRef
8. Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA. 2006;296:2683
   • CrossRef